ABSTRACT The present invention relates to pharmaceutical composition of estrogen receptor modulator for the method of treatment of hepatitis C in humans. The methods of the present invention can be used in patients with hepatitis C administering estrogen receptor modulator preferably Hexestrol, optionally in combination with one or more anti-hepatitis C drugs.
